Thomas J. Jr. Lynch
CIK 1474056 · EVP & Chief Scientific Officer · last filed 2025-06-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.36M
Companies
3
Total Filings
33
Lifetime Open-Market Net
-$335.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 4
33 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-07-01 | BMY | Grant (A) | — | $0 | EDGAR |
| 2015-04-02 | BMY | Grant (A) | — | $0 | EDGAR |
| 2015-02-03 | BMY | Grant (A) | — | $0 | EDGAR |
| 2015-01-05 | BMY | Grant (A) | — | $0 | EDGAR |
| 2014-10-02 | BMY | Grant (A) | — | $0 | EDGAR |
| 2014-07-02 | BMY | Grant (A) | — | $0 | EDGAR |
| 2014-02-04 | BMY | Grant (A) | — | $0 | EDGAR |
| 2014-01-02 | BMY | Grant (A) | — | $0 | EDGAR |
| 2013-06-13 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-05-18 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.